Unlocking the power of diversity-driven discovery and development to amplify success of bispecific lead generation
Time: 3:30 pm
day: Day Two
Details:
- Current challenges in generating bispecific antibody therapeutics – solving the combinatorial matrix puzzle and fast-tracking bispecific generation for early-stage functional assessment.
- Fully customized bispecific antibody generation workflow from discovery, characterization to pre-clinical production to pave the path from concept to clinical lead
- Multiparametric, high throughput in silico-driven molecular optimization to derisk programs as early as possible